3D bioprinting is a method comprising cells and biomaterials for the production of biomedical parts. The global 3D bioprinting market report by Market Research Future (MRFR) contains drivers, challenges, opportunities, and trends for the forecast period. The outbreak of the COVID-19 pandemic and its impact on the industry has been analyzed thoroughly in the report.
The global 3D bioprinting market size can reach USD 1,923.02 million by 2023, as per MRFR. It can display a CAGR of 24.59% over the forecast period. According to the National Kidney Foundation, there are 121,678 people awaiting organ transplants in the U.S. The cost-economical value of 3D bioprinting for treatment of craniofacial and dental disorders is paving the way for the market.
The market is expected to garner heavy demand owing to the need to curtail production costs across all industries. The low cost can lead to higher profit margins for the producers. The application of 3D bioprinting in organ transplantation is likely to fuel the market growth.
Emergence of various startups such as Cyfuse Biomedical and Nano 3D Bioscience are expected to bode well for the market and lower the prices due to the competition. Investments in biotechnology and healthcare are expected to bode well for the global 3D bioprinting market. Development of bioinks Top 3D bioprinting companies include Poietis, Allevi, Regenovo Biotechnology Co. Ltd., Organovo Holdings Inc., EnvisionTEC GmbH, REGENHU Ltd., FUJIFILM Wako Automation Corporation, Cellink AB, Stratasys Ltd., Aspect Biosystems Ltd., Nano3D Biosciences Inc., and Cyfuse Biomedical K.K.
The 3D bioprinting market is segmented by technology, material, application, and end-user.
- By Technologies of 3D bioprinting are laser-assisted bioprinting, microextrusion bioprinting, magnetic 3D bioprinting, and inkjet 3D bioprinting. Microextrusion bioprinting is being used to increase the densities of cell structures and the use of bioinks for creating cell matrices.
- By Material, the market is segmented into living cells, extracellular matrices, and hydrogels. Living cells held a major market share due to the use of in-air microfluidics. Its compatibility with biomaterials will propel the global 3D bioprinting market revenues till 2023.
- By Applications in the 3D bioprinting market include research and clinical applications.
- By End-users in the 3D bioprinting market include pharmaceutical & biotechnology companies and research organizations & academic institutes.
Based on regions, the 3D bioprinting market is segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).
Among these, the Americas were the dominant regions of the market in 2017 owing to demand for 3D products, presence of various additive manufacturers, and high disposable income levels of patients.
It has the potential to reach a value of USD 689.91 million by 2023. The global 3D bioprinting market is likely to thrive owing to presence of various companies and a plethora of opportunities in aerospace, automotive, and healthcare sectors.
On the other hand, the APAC region is touted to display the highest CAGR of 27.25% over the assessment period. Factors driving regional market growth include the developing healthcare sector in China and rise in funding for research and development.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future (MRFR) team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York, New York 10013,
United States of America
+1 646 845 9312